key: cord-0868127-h1b5ckgu
authors: Belaid, Brahim; Lamara Mahammad, Lydia; Mihi, Belgacem; Rahali, Sarah Yasmine; Djidjeli, Asma; Larab, Zineb; Berkani, Lilya; Berkane, Ismahane; Sayah, Wafa; Merah, Fatma; Lazli, Nouzha Zhor; Kheddouci, Lylia; Kadi, Ahmed; Ouali, Mourad; Khellafi, Rachida; Mekideche, Dalila; Kheliouen, Assia; Ayoub, Soraya; Hamidi, Réda Malek; Derrar, Fawzi; Gharnaout, Merzak; Allam, Ines; Djidjik, Réda
title: T cell counts and IL‐6 concentration in blood of North African COVID‐19 patients are two independent prognostic factors for severe disease and death
date: 2021-02-02
journal: J Leukoc Biol
DOI: 10.1002/jlb.4cova1020-703r
sha: f25de30de348aa3b388b1a19f659d48d2dc5e432
doc_id: 868127
cord_uid: h1b5ckgu

The immune system plays a crucial role in the response against severe acute respiratory syndrome coronavirus 2 with significant differences among patients. The study investigated the relationships between lymphocyte subsets, cytokines, and disease outcomes in patients with coronavirus disease 2019 (COVID‐19). The measurements of peripheral blood lymphocytes subsets and cytokine levels were performed by flow cytometry for 57 COVID‐19 patients. Patients were categorized into two groups according to the severity of the disease (nonsevere vs. severe). Total lymphocytes, T cells, CD4+ T cells, CD8+ T cells, B cells, and natural killer cells were decreased in COVID‐19 patients and statistical differences were found among different severity of illness and survival states (P ˂ 0.01). The levels of IL‐6 and IL‐10 were significantly higher in severe and death groups and negatively correlated with lymphocyte subsets counts. The percentages of Th17 in the peripheral blood of patients were higher than those of healthy controls whereas the percentages of Th2 were lower. For the severe cases, the area under receiver operating characteristic (ROC) curve of IL‐6 was the largest among all the immune parameters (0.964; 95% confidence interval: 0.927–1.000, P < 0.0001). In addition, the preoperative IL‐6 concentration of 77.38 pg/ml was the optimal cutoff value (sensitivity: 84.6%, specificity: 100%). Using multivariate logistic regression analysis and ROC curves, IL‐6 > 106.44 pg/ml and CD8+ T cell counts <150 cells/μl were found to be associated with mortality. Measuring the immune parameters and defining a risk threshold can segregate patients who develop a severe disease from those with a mild pathology. The identification of these parameters may help clinicians to predict the outcome of the patients with high risk of unfavorable progress of the disease.

In 2019, a new coronavirus was identified as the cause of a disease outbreak that emerged in Wuhan, a city in Hubei's province in China. This novel virus referred to as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread to other provinces of China and to other countries, hence becoming a global health threat and triggering unprecedented measures worldwide. In February 2020, the World Health Organization (WHO) formally named this respiratory infection coronavirus disease 2019 . A month later, the rapidly escalating health crisis led the WHO to declare the SARS-COV-2 outbreak a pandemic. 1 As of December 27, the virus had infected at least 79 million people worldwide resulting in more than 1.7 million deaths. On the same day, 97,857 cases were reported in Algeria with an apparent fatality rate of 2.78%. 2 Although most of SARS-CoV-2 infected patients generally display mild-to-moderate symptoms and undergo spontaneous regression, approximately 14% of infected subjects experience a severe disease characterized by a significant hypoxia inherent to the respiratory distress syndrome. The remaining COVID-19 patients, who are mainly individuals over 60 and/or with comorbidities, develop a critical condition, which requires admission to the intensive care unit. 3 It is likely that the variation in the overall immune response to SARS-CoV- Among these factors lymphocytes counts and cytokines levels have been of great interest. 6, 7 The aim of this single-center study was to characterize the changes of peripheral blood lymphocyte subsets and quantify plasma cytokine levels in an Algerian cohort of SARS-CoV-2 infected patients with distinct disease severity. In addition, the study explored the predictive value of these parameters as a prognosis tool to determine the mortality and severity risks in COVID-19 patients.

This study was conducted at the department of medical immunology For the purpose of the following study, the cases were divided into nonsevere (mild to moderate) and severe groups (severe to critical).

Data on demographic characteristics, comorbidities, severity assessment on admission, as well as clinical outcomes were retrieved from a medical record system. All data were reviewed and validated by a team of trained physicians. 

For the immune cell phenotyping, 1 ml of peripheral blood (EDTAanticoagulated whole blood) was used within 8 h from collection.

Lymphocytes were stained with the monoclonal antibodies listed in the Supporting Information Table S1 . After red blood cell removal using a lysis buffer followed by washing steps, cells were stained and acquired using a BD FACSLyric flow cytometer (Becton Dickinson) and the data were analyzed using BD FACSuite Software (BD Biosciences).

Lymphocyte subsets were defined as follows10: T cells (CD3+), 

A total of 57 patients with SARS-CoV-2 infection were included in this study. The baseline characteristics of patients were summarized in 

Data are expressed as mean ± SD or n/N (%), where N is the total number of patients with available data. P-values comparing nonsevere and severe group are from independent group t-test, 2 , or Fisher's exact test.

The quantification of peripheral blood lymphocyte subsets shown in Table 2 and Supporting Information Table S2 were compared with those already established in the literature as a reference 10 In order to characterize the nature of CD4 T helper response to SARS-CoV-2 infection, the percentages of CD4+IFN + (Th1), CD4+IL-4+ (Th2), and CD4+IL-17A+ (Th17) cells were assessed by flow cytometry. As shown in Figure 1C and Table 2 , COVID-19 patients exhibited a significant reduction in the proportion of IL-4 producing CD4+ T cells and a significant increase of Th17 frequency when compared to healthy subjects (P < 0.0001 and P = 0.009). On the other hand, only a significant decrease of Th1 cells was observed in the patients who died compared to those who recovered (P = 0.042). Interestingly, no differences were found between nonsevere and severe cases in terms Th frequencies. Besides the analysis of Th populations, the study also assessed plasma cytokine levels in these patients ( Table 2 ). IL-6 and IL-10 concentrations were markedly higher in deceased cases compared to the survivors (P < 0.001 and P = 0.001) (Fig. 1E ). The patients who had a severe clinical disease showed a significant increase of IL-6, IL-10, and IFN (P < 0.001, P = 0.001 and P = 0.038) (Fig. 1D ).

In order to gain a broader understanding of the immune response 

As previously described, low count of lymphocyte subsets and high levels of cytokines were associated with increased disease severity. ROC curve and area under ROC curve (AUC) were generated to evaluate the potential use of these parameters as diagnosis tool to identify severe cases. As shown in Figure 3 and Supporting Information 

As shown in Supporting Information Table 4 ). The Nagelkerke R 2 value was 0.741.

In the light of these data, the study assigned patients into four 

Here, the study presents an immune cell profiling in a cohort of 57 COVID-19 patients with a particular emphasis on lymphocytes. Our T cells were shown to display potent cytotoxicity and home efficiently to inflamed peripheral tissues, whereas central memory home to secondary lymphoid organs and display a high proliferative capacity. 36 Antigen recognition leads to the activation of T cells followed by the loss of CD45RA expression and the acquisition of CD45RO isoform. 37 Therefore, early studies considered that the expression of CD45RA

in T cells as an indication of a naïve state, whereas CD45RO+ T cells were defined as a pool of antigen-experienced T cells, mainly composed of recently activated effector and memory T cells. 37 However, subsequent reports have demonstrated that T cells, which encountered an antigen may revert from a primed CD45RO+ to a CD45RA+ phenotype, 38, 39 entailing that the CD45RA+ T cells may contain a fraction of antigen-experienced clones. Unfortunately, the surface markers used in the current study were not suitable for the accurate characterization of naïve CD4+ T cell subsets. It is now widely accepted that after the thymic involution the maintenance of T cells is exclusively achieved through a peripheral expansion resulting in different patterns of naïve T cells in the young and elderly. 40, 41 As a consequence, these events might substantially influence the potential of T cell activation and subsequently T cell differentiation. 42, 43 Therefore, it is tempting to speculate that the low frequency of a severe COVID-19 cases in young subjects is at least partly due to a difference in the nature of T cells between young and old patients.

During an infection, the initial antigen priming of naïve CD4 T cells combined to specific cues provided by cytokines signaling lead to their differentiation into at least four distinct subsets including Th1, Th2, Th17, and iTreg. The phenotypic and functional identity of T helper cells is defined by the pattern of the cytokines produced following their differentiation. 44 also evaluated the capacity of CD4+ T cells to produce IFN , an important cytokine that promotes antiviral immunity. 47 No significant difference has been found between patients and healthy controls; however, the patients who died showed reduced frequency of IFN producing CD4+ T cells compared to those who survived. This indicates that a poor outcome is not only associated with a decreased number of lymphocyte counts but also with an impaired CD4 T cell functionality. 48 Effective prediction criteria can allow physicians to provide an appropriate medical care for the patients with severe COVID-19. A ROC curve analysis showed that low count of lymphocyte subsets and high levels of IL-6 and IL-10 have a potential value to segregate patients with a severe disease from those who experienced a mild pathology. In addition, the aforementioned parameters allowed predicting a fatal outcome in our cohort of COVID-19 patients. Moreover, potential mortality risk factors for COVID-19 were analyzed by a multivariable binary logistic regression. The results indicated that a CD8+ T cell counts <150 cells/ l and IL-6 >106.44 pg/ml are two independent prognostic factors for death. Similar results were documented in another study, 49 which showed that CD8+ T cell counts <165 cells/ l and IL-6 > 20 pg/ml are two reliable prognosis indicators that accurately stratify patients into risk categories and predict COVID-19 mortality. Furthermore, the ROC curve of the model combining these two parameters was reported to display a better performance than the commonly used CURB-65 scores (confusion, urea, respiratory rate, blood pressure, and age).

It is worth noting that our study has some limitations. First, this was a pilot single-center study with a small sample size. Hence, a multicen-ter study with larger cohort would significantly enhance the strength of our findings. Second, quantification of soluble cytokines was performed only in the patients with COVID-19. In fact, the recruitment of healthy subjects was extremely difficult during the peak of the pandemic because of the multiple preventive measures to limit the spread of infection. Moreover, some patients with COVID-19

have developed a bacterial superinfection, which probably influenced their immunologic parameters. Further, 6.9% (95% CI, 4.3-9.5%) of patients with COVID-19 develop a bacterial infection that contributes to the exacerbation of the disease. 50 

Coronaviruses and SARS-CoV-2: a brief overview

COVID-19 weekly epidemiological update

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). WHO-China Jt Mission Coronavirus Dis

Immune parameters and COVID-19 infection-associations with clinical severity and disease prognosis

Immunology of COVID-19: current state of the science

Laboratory findings of COVID-19: a systematic review and meta-analysis

Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis

Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance 28

Diagnosis and treatment protocol for novel coronavirus pneumonia

Establishment of normative ranges of the healthy human immune system with comprehensive polychromatic flow cytometry profiling

Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines

Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impacts viral set point

Human Ebola virus infection results in substantial immune activation

Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 disease. Nat Commun

Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan

Dysregulation of immune response in patients with COVID-19 in Wuhan, China

Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)

Leucocyte subsets effectively predict the clinical outcome of patients with COVID-19 pneumonia: a retrospective casecontrol study

Decreased T cell populations contribute to the increased severity of COVID-19

Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia

Analysis of serum cytokines in patients with severe acute respiratory syndrome

Clinical progression and cytokine profiles of Middle East respiratory syndrome coronavirus infection

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

COVID-19 pneumonia: CD8 + T and NK cells are decreased in number but compensatory increased in cytotoxic potential

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Virological assessment of hospitalized patients with COVID-2019. Nature;581. Epub ahead of print 2020

Longitudinal characteristics of lymphocyte responses and cytokine pro fi les in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine;55. Epub ahead of print 2020

IL-6 in inflammation, immunity, and disease

severe pulmonary syndrome patients of a new coronavirus. bioRxiv Prepr. Epub ahead of print 2020

COVID-19 infection induces readily detectable morphological and inflammation-related phenotypic changes in peripheral blood monocytes, the

Clinical and Translational Report Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure ll Clinical and Translational Report Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Cytokine storm and sepsis disease pathogenesis

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome

Defining memory CD8 T cell

Limiting dilution analysis of proliferative responses in human lymphocyte populations defined by the monoclonal antibody UCHL1: implications for differential CD45 expression in T cell memory formation

Interconversion of CD45R subsets of CD4 T cells in vivo

Lifespan of human lymphocyte subsets defined by CD45 isoforms

Life after the thymus: CD31+ and CD31 human naive CD4+ T-cell subsets

Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans

Postthymic expansion in human CD4 naive T cells defined by expression of functional highaffinity IL-2 receptors

Cell generation dynamics underlying naive T-cell homeostasis in adult humans

Differentiation of effector CD4 T cell populations

The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement

TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib

Direct antiviral mechanisms of interferin-gamma

Clinical and immunological features of severe and moderate coronavirus disease 2019 clinical and immunological features of severe and moderate coronavirus disease 2019

IL-6 and CD8 + T cell counts combined are an early predictor of in-hospital mortality of patients with COVID-19. 5. Epub ahead of print 2020

Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis

Lymphocyte subset numbers depend on the bacterial origin of sepsis

Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients

How to cite this article

T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death

The authors thank Dr. Mark Bix for his critical reading of the manuscript. They also thank Mohamad Kurdi for the technical support.

The authors declare no conflicts of interest.